Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ALK tyrosine kinase receptor (Homo sapiens (Human)) | BDBM50436850![]() (CERITINIB | CHEMBL2403108 | LDK378 | US10053458, C...) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | Purchase CHEMBL MMDB PC cid PC sid PDB UniChem Similars | PDB US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
Suzhou Zelgen Biopharmaceuticals Co., Ltd. US Patent | Assay Description 96-well plates was coated under 37° C. with coating buffer (125 μl/well) overnight, and coating buffer was polypeptide substrate [Poly (4:1 Glu,... | US Patent US10618884 (2020) | |||||||||||
More data for this Ligand-Target Pair | ![]() 3D Structure (crystal) | ||||||||||||
ALK tyrosine kinase receptor (Homo sapiens (Human)) | BDBM50436850![]() (CERITINIB | CHEMBL2403108 | LDK378 | US10053458, C...) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | Purchase CHEMBL MMDB PC cid PC sid PDB UniChem Similars | PDB US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
Suzhou Zelgen Biopharmaceuticals Co., Ltd. US Patent | Assay Description 96-well plates was coated under 37° C. with coating buffer (125 μl/well) overnight, and coating buffer was polypeptide substrate [Poly (4:1 Glu,... | US Patent US10618884 (2020) | |||||||||||
More data for this Ligand-Target Pair | ![]() 3D Structure (crystal) | ||||||||||||
ALK tyrosine kinase receptor (Homo sapiens (Human)) | BDBM50436850![]() (CERITINIB | CHEMBL2403108 | LDK378 | US10053458, C...) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | Purchase CHEMBL MMDB PC cid PC sid PDB UniChem Similars | PDB US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
Suzhou Zelgen Biopharmaceuticals Co., Ltd. US Patent | Assay Description 96-well plates was coated under 37° C. with coating buffer (125 μl/well) overnight, and coating buffer was polypeptide substrate [Poly (4:1 Glu,... | US Patent US10618884 (2020) | |||||||||||
More data for this Ligand-Target Pair | ![]() 3D Structure (crystal) | ||||||||||||
ALK tyrosine kinase receptor (Homo sapiens (Human)) | BDBM50436850![]() (CERITINIB | CHEMBL2403108 | LDK378 | US10053458, C...) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | Purchase CHEMBL MMDB PC cid PC sid PDB UniChem Similars | PDB US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
Suzhou Zelgen Biopharmaceuticals Co., Ltd. US Patent | Assay Description 96-well plates was coated under 37° C. with coating buffer (125 μl/well) overnight, and coating buffer was polypeptide substrate [Poly (4:1 Glu,... | US Patent US10618884 (2020) | |||||||||||
More data for this Ligand-Target Pair | ![]() 3D Structure (crystal) | ||||||||||||
ALK tyrosine kinase receptor (Homo sapiens (Human)) | BDBM50436850![]() (CERITINIB | CHEMBL2403108 | LDK378 | US10053458, C...) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | Purchase CHEMBL MMDB PC cid PC sid PDB UniChem Similars | PDB US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
Suzhou Zelgen Biopharmaceuticals Co., Ltd. US Patent | Assay Description 96-well plates was coated under 37° C. with coating buffer (125 μl/well) overnight, and coating buffer was polypeptide substrate [Poly (4:1 Glu,... | US Patent US10618884 (2020) | |||||||||||
More data for this Ligand-Target Pair | ![]() 3D Structure (crystal) | ||||||||||||
ALK tyrosine kinase receptor (Homo sapiens (Human)) | BDBM50436850![]() (CERITINIB | CHEMBL2403108 | LDK378 | US10053458, C...) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | Purchase CHEMBL MMDB PC cid PC sid PDB UniChem Similars | PDB US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
Suzhou Zelgen Biopharmaceuticals Co., Ltd. US Patent | Assay Description 96-well plates was coated under 37° C. with coating buffer (125 μl/well) overnight, and coating buffer was polypeptide substrate [Poly (4:1 Glu,... | US Patent US10618884 (2020) | |||||||||||
More data for this Ligand-Target Pair | ![]() 3D Structure (crystal) | ||||||||||||
ALK tyrosine kinase receptor (Homo sapiens (Human)) | BDBM50436850![]() (CERITINIB | CHEMBL2403108 | LDK378 | US10053458, C...) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | Purchase CHEMBL MMDB PC cid PC sid PDB UniChem Similars | PDB US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
Suzhou Zelgen Biopharmaceuticals Co., Ltd. US Patent | Assay Description 96-well plates was coated under 37° C. with coating buffer (125 μl/well) overnight, and coating buffer was polypeptide substrate [Poly (4:1 Glu,... | US Patent US10618884 (2020) | |||||||||||
More data for this Ligand-Target Pair | ![]() 3D Structure (crystal) | ||||||||||||
ALK tyrosine kinase receptor (Homo sapiens (Human)) | BDBM50436850![]() (CERITINIB | CHEMBL2403108 | LDK378 | US10053458, C...) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | Purchase CHEMBL MMDB PC cid PC sid PDB UniChem Similars | PDB US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
Suzhou Zelgen Biopharmaceuticals Co., Ltd. US Patent | Assay Description 96-well plates was coated under 37° C. with coating buffer (125 μl/well) overnight, and coating buffer was polypeptide substrate [Poly (4:1 Glu,... | US Patent US10618884 (2020) | |||||||||||
More data for this Ligand-Target Pair | ![]() 3D Structure (crystal) | ||||||||||||
ALK tyrosine kinase receptor (Homo sapiens (Human)) | BDBM50436850![]() (CERITINIB | CHEMBL2403108 | LDK378 | US10053458, C...) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | Purchase CHEMBL MMDB PC cid PC sid PDB UniChem Similars | PDB US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
Suzhou Zelgen Biopharmaceuticals Co., Ltd. US Patent | Assay Description 96-well plates was coated under 37° C. with coating buffer (125 μl/well) overnight, and coating buffer was polypeptide substrate [Poly (4:1 Glu,... | US Patent US10618884 (2020) | |||||||||||
More data for this Ligand-Target Pair | ![]() 3D Structure (crystal) | ||||||||||||
ALK tyrosine kinase receptor (Homo sapiens (Human)) | BDBM50436850![]() (CERITINIB | CHEMBL2403108 | LDK378 | US10053458, C...) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | Purchase CHEMBL MMDB PC cid PC sid PDB UniChem Similars | PDB US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
Suzhou Zelgen Biopharmaceuticals Co., Ltd. US Patent | Assay Description 96-well plates was coated under 37° C. with coating buffer (125 μl/well) overnight, and coating buffer was polypeptide substrate [Poly (4:1 Glu,... | US Patent US10618884 (2020) | |||||||||||
More data for this Ligand-Target Pair | ![]() 3D Structure (crystal) | ||||||||||||
ALK tyrosine kinase receptor (Homo sapiens (Human)) | BDBM50436850![]() (CERITINIB | CHEMBL2403108 | LDK378 | US10053458, C...) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | Purchase CHEMBL MMDB PC cid PC sid PDB UniChem Similars | PDB US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
Suzhou Zelgen Biopharmaceuticals Co., Ltd. US Patent | Assay Description 96-well plates was coated under 37° C. with coating buffer (125 μl/well) overnight, and coating buffer was polypeptide substrate [Poly (4:1 Glu,... | US Patent US10618884 (2020) | |||||||||||
More data for this Ligand-Target Pair | ![]() 3D Structure (crystal) | ||||||||||||
ALK tyrosine kinase receptor (Homo sapiens (Human)) | BDBM50436850![]() (CERITINIB | CHEMBL2403108 | LDK378 | US10053458, C...) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | Purchase CHEMBL MMDB PC cid PC sid PDB UniChem Similars | PDB US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
Suzhou Zelgen Biopharmaceuticals Co., Ltd. US Patent | Assay Description 96-well plates was coated under 37° C. with coating buffer (125 μl/well) overnight, and coating buffer was polypeptide substrate [Poly (4:1 Glu,... | US Patent US10618884 (2020) | |||||||||||
More data for this Ligand-Target Pair | ![]() 3D Structure (crystal) | ||||||||||||
ALK tyrosine kinase receptor (Homo sapiens (Human)) | BDBM50436850![]() (CERITINIB | CHEMBL2403108 | LDK378 | US10053458, C...) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | Purchase CHEMBL MMDB PC cid PC sid PDB UniChem Similars | PDB US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
Suzhou Zelgen Biopharmaceuticals Co., Ltd. US Patent | Assay Description 96-well plates was coated under 37° C. with coating buffer (125 μl/well) overnight, and coating buffer was polypeptide substrate [Poly (4:1 Glu,... | US Patent US10618884 (2020) | |||||||||||
More data for this Ligand-Target Pair | ![]() 3D Structure (crystal) | ||||||||||||
ALK tyrosine kinase receptor (Homo sapiens (Human)) | BDBM50436850![]() (CERITINIB | CHEMBL2403108 | LDK378 | US10053458, C...) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | Purchase CHEMBL MMDB PC cid PC sid PDB UniChem Similars | PDB US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
Suzhou Zelgen Biopharmaceuticals Co., Ltd. US Patent | Assay Description 96-well plates was coated under 37° C. with coating buffer (125 μl/well) overnight, and coating buffer was polypeptide substrate [Poly (4:1 Glu,... | US Patent US10618884 (2020) | |||||||||||
More data for this Ligand-Target Pair | ![]() 3D Structure (crystal) | ||||||||||||
ALK tyrosine kinase receptor (Homo sapiens (Human)) | BDBM50436850![]() (CERITINIB | CHEMBL2403108 | LDK378 | US10053458, C...) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | Purchase CHEMBL MMDB PC cid PC sid PDB UniChem Similars | PDB US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
Suzhou Zelgen Biopharmaceuticals Co., Ltd. US Patent | Assay Description 96-well plates was coated under 37° C. with coating buffer (125 μl/well) overnight, and coating buffer was polypeptide substrate [Poly (4:1 Glu,... | US Patent US10618884 (2020) | |||||||||||
More data for this Ligand-Target Pair | ![]() 3D Structure (crystal) | ||||||||||||
ALK tyrosine kinase receptor (Homo sapiens (Human)) | BDBM50436850![]() (CERITINIB | CHEMBL2403108 | LDK378 | US10053458, C...) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | Purchase CHEMBL MMDB PC cid PC sid PDB UniChem Similars | PDB US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
Suzhou Zelgen Biopharmaceuticals Co., Ltd. US Patent | Assay Description 96-well plates was coated under 37° C. with coating buffer (125 μl/well) overnight, and coating buffer was polypeptide substrate [Poly (4:1 Glu,... | US Patent US10618884 (2020) | |||||||||||
More data for this Ligand-Target Pair | ![]() 3D Structure (crystal) |